[12] Angela M. Davies, Uri Weinberg, and Yoram Palti. Tumor treating ?elds: a new frontier in cancer therapy. New York Academy of Sciences. 1291 (2013) 86–95. doi: 10.1111/nyas.12112

[13] Stupp, R., Wong, E. T., Kanner, A. A., et al. NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality. European Journal of Cancer.48:14 (2012),2192–2202. doi:10.1016/j.ejca.2012.04.011

[14] Wolfgang Wick. TTFields: where does all the skepticism come from? Neuro-Oncology.18:3(2016), 303–305. doi:10.1093/neuonc/now012

[15] Toms, S. A., Kim, C. Y., Nicholas, G., & Ram, Z. Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial. Journal of Neuro-Oncology.141:2(2018),467–473. doi:10.1007/s11060-018-03057-z

• 有癌症，易房颤！韩国82万例患者研究
• 心衰治疗里程碑突破！首个miRNA药物证明安全有效！
• 深圳科学家提出肿瘤精准治疗新思路
• 淋巴瘤患者的福音！苏州大学探寻新的治疗靶点
• 晚期癌症只能活活痛死？癌症根本不用治？肿瘤科医生讲了四个真相
• 【医伴旅】200mg剂量的非戈替尼治疗中重度溃疡性结肠炎安全有效
• 癌症会一代传一代？父母若得了5种癌，子女可能会“继承”
• 医万个为什么 | 康焱：关节严重变形，为什么手术是唯一治疗方法？
• EULAR重磅更新：GRAPPA发布PsA治疗最新建议！IL-17抑制剂获一线推荐！
• 医疗|长期染发会致癌吗？提醒：一种染发剂与癌症相关，学会4个技巧